Questcor Pharma (QCOR) to Hold Conf. Call Following 48% Dive on Acthar Concerns

September 20, 2012 7:16 AM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Trade QCOR Now!
Join SI Premium – FREE
Questcor Pharmacueticals, Inc. (Nasdaq: QCOR) shares are a little higher Thursday morning following a massive 48 percent drop on Wednesday. The reason was concern that Aetna was going to drop reimbursement for Acthar Gel.

Questcor said it will be holding a conference call today to discuss the reimbursement process for H.P. Acthar Gel (repository corticotrophin injection) prescriptions. The call will take place on Thursday, September 20, 2012 at 11 a.m. ET, 8 a.m. PT. The call can be accessed in the following ways:
  • By webcast: At Questcor's investor relations website: http://ir.questcor.com/.

  • By telephone: For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-941-9205. For participants outside the U.S., the dial-in number is 480-629-9771.

  • By audio replay: A replay of the conference call will be available for seven business days following conclusion of the live call. The dial-in number for U.S. participants is 800-406-7325. For participants outside the U.S., the replay dial-in number is 303-590-3030. The replay access code for all callers is 4566307#

  • Or, visit the office:

    Questcor Pharmaceuticals, Inc.
    1300 North Kellogg Drive, Suite D
    Anaheim Hills, CA 92807


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Conference Calls, FDA, Momentum Movers

Add Your Comment